Skip to main content
. 2019 May 13;21(5):e11349. doi: 10.2196/11349

Table 2.

Baseline adjusted symptom measures at 3, 6, and 15 months: guided Web-based rumination-focused cognitive behavioral therapy versus usual care controls.

Timepoint and measure Guided Web-based rumination-focused cognitive behavioral therapy, mean (95% CI) Usual care, mean (95% CI) Between-group difference, difference (95% CI) Estimated between-group difference after multiple imputations, multiple imputation difference (95% CI)
Follow-up 1 (3 months; n=114)
PHQ-9a 4.75 (3.74 to 5.76) 5.40 (4.48 to 6.33) −0.65b (−2.02 to 0.72) −0.55b (−2.05 to 0.96)
GAD-7c 5.58 (4.51 to 6.66) 6.27 (5.28 to 7.25) −0.69b (−2.15 to 0.78) −0.53b (−2.14 to 1.09)
PSWQd 57.27 (54.85 to 59.69) 58.45 (56.23 to 60.67) −1.18b (−4.46 to 2.11) −0.75b (−4.35 to 2.86)
RRSe 44.34 (41.66 to 47.02) 48.21 (45.73 to 50.68) −3.87f (−7.53 to −0.21) −3.69b (−8.01 to 0.63)
Follow-up 2 (6 months; n=105)
PHQ-9 3.70 (2.48 to 4.92) 5.52 (4.42 to 6.62) −1.82f (−3.46 to −0.18) −1.97f (−3.87 to −.063)
GAD-7 4.72 (3.44 to 5.99) 6.06 (4.91 to 7.20) −1.34b (−3.05 to 0.38) −1.15b (−3.16 to 0.85)
PSWQ 54.83 (52.19 to 57.48) 58.41 (56.03 to 60.79) −3.58f (−7.14 to −0.02) −2.71b (−6.68 to 1.25)
RRS 41.74 (38.15 to 45.34) 46.35 (43.12 to 49.58) −4.60b (−9.47 to 0.26) −3.98b (−9.48 to 1.52)
Follow-up 3 (15 months; n=108)
PHQ-9 4.47 (3.23 to 5.71) 4.82 (3.73 to 5.91) −0.35b (−2.00 to 1.30) −0.38b (−2.30 to 1.55)
GAD-7 4.42 (3.16 to 5.68) 5.73 (4.62 to 6.83) −1.31b (−2.99 to 0.38) −1.10b (−2.10 to 0.80)
PSWQ 54.81 (51.71 to 57.91) 58.11 (55.39 to 60.84) −3.30b (−7.43 to 0.82) −1.74b (−6.53 to 3.06)
RRS 46.15 (42.59 to 49.72) 44.65 (41.53 to 47.78) 1.50b (−3.28 to 6.28) 1.16b (−3.99 to 6.31)

aPHQ-9: Patient Health Questionnaire.

bNot significant.

cGAD-7: Generalized Anxiety Disorder Screener.

dPSWQ: Penn State Worry Questionnaire.

en=115 for Ruminative Response Scale (RRS) at 3 months owing to one partially completed questionnaire set.

fP<.05.